Document is current
Any future updates will be listed below
-
Authors
Geva, Ravit
Alon, Gilad
Nathanson, Maya
Bar-David, Shoshi
Nevo, Nadav
Aizic, Asaf
Peles-Avraham, Sharon
Lahat, Guy
Nizri, Eran https://orcid.org/0000-0001-7935-2372
- License Information
-
More Information
Article History
Received: 30 August 2022
Accepted: 13 December 2022
First Online: 3 January 2023
Disclosures
: Ravit Geva has received honoraria (self) from Roche, MSD, Merck, Medison, Janssen, Pfizer, and BMS, and advisory/consultancy fees from AstraZeneca, BOL Pharma, Roche, Ranium, JNJ, Bayer, and MSD; holds a leadership role with Pyxis (medical lead); has shareholder/stockholder/stock options with Pyxis (options); and has received travel/accommodation expenses from Takeda and Medison. Gilad Alon, Maya Nathanson, Shoshi Bar-David, Nadav Nevo, Asaf Aizic, Sharon Peles-Avraham, Guy Lahat and Eran Nizri have no disclosures to declare.
